THE ROLE OF PROSTAGLANDINS IN THE TREATMENT OF POSTPARTUM HEMORRHAGE

Adrinopoulis G.C., Mendenhall H.W., Prostaglandin F_2α, in the management of delayed postpartum hemorrhage, American Journal of Obstetrics and Gynecology, 146, pp. 217-218, (1983)

Anathasubramaniam L., Kuntal R., Sivaraman R., Raghaven K.S., Management of intractable postpartum hemorrhage secondary to uterine atony with intramuscular 15(S) 15 methyl PGF₂ alpha, Acta Obstetricia el Gynecologica Scandinavica, 145, pp. 17-19, (1988)

Anjaneyulu R., Devi P.K., Jain S., Kanthamani Vijaya C.R.R., Raghaven K.S., Prophylactic use of 15(S) 15 methyl PGF₂ alpha by intramuscular route—a controlled clinical trial, Acta Obstetricia et Gynecologica Scandinavica, 145, pp. 9-11, (1988)

Bruce S.L., Paul R.H., Van Dorsten J.B., Control of postpartum uterine atony by intramyometrial prostaglandin, Obstetrics and Gynecology, 59, pp. 47-50, (1983)

Buttino L., Garite T.J., The use of 15 methyl F₂ alpha prostaglandin (Prostin 15M) for the control of postpartum hemorrhage, American Journal of Perinatology, 3, pp. 241-243, (1986)

Bygdeman M., Kwon S.U., Mukherjee, Wiqvist N., Effect of intravenous infusion of prostaglandin E₁ and E₂ on motility of the pregnant human uterus, American Journal of Obstetrics and Gynecology, 102, pp. 317-326, (1985)

Corson S.L., Bolognese R.L., Postpartum uterine atony treated with prostaglandins, American Journal of Obstetrics and Gynecology, 129, pp. 918-919, (1977)

Goldstein A.J., Kent D.R., David A., Prostaglandin E₂ vaginal suppositories in the treatment of intractable late-onset postpartum hemorrhage. A case report, Journal of Reproductive Medicine, 28, pp. 425-426, (1983)

Hayashi R.H., Castillo M.S., Noah M.L., Management of severe postpartum hemorrhage due to uterine atony using an analogue of prostaglandin F₂ alpha, Obstetrics and Gynecology, 58, pp. 426-429, (1981)

Hayashi R.H., Castillo M.S., Noah M.L., Management of severe postpartum hemorrhage with a prostaglandin F₂ alpha analogue, Obstetrics and Gynecology, 63, pp. 806-808, (1984)

Adrinopoulis G.C., Mendenhall H.W., Prostaglandin F_2α, in the management of delayed postpartum hemorrhage, American Journal of Obstetrics and Gynecology, 146, pp. 217-218, (1983)

Anathasubramaniam L., Kuntal R., Sivaraman R., Raghaven K.S., Management of intractable postpartum hemorrhage secondary to uterine atony with intramuscular 15(S) 15 methyl PGF₂ alpha, Acta Obstetricia el Gynecologica Scandinavica, 145, pp. 17-19, (1988)

Anjaneyulu R., Devi P.K., Jain S., Kanthamani Vijaya C.R.R., Raghaven K.S., Prophylactic use of 15(S) 15 methyl PGF₂ alpha by intramuscular route—a controlled clinical trial, Acta Obstetricia et Gynecologica Scandinavica, 145, pp. 9-11, (1988)

Bruce S.L., Paul R.H., Van Dorsten J.B., Control of postpartum uterine atony by intramyometrial prostaglandin, Obstetrics and Gynecology, 59, pp. 47-50, (1983)

Buttino L., Garite T.J., The use of 15 methyl F₂ alpha prostaglandin (Prostin 15M) for the control of postpartum hemorrhage, American Journal of Perinatology, 3, pp. 241-243, (1986)

Bygdeman M., Kwon S.U., Mukherjee, Wiqvist N., Effect of intravenous infusion of prostaglandin E₁ and E₂ on motility of the pregnant human uterus, American Journal of Obstetrics and Gynecology, 102, pp. 317-326, (1985)

Corson S.L., Bolognese R.L., Postpartum uterine atony treated with prostaglandins, American Journal of Obstetrics and Gynecology, 129, pp. 918-919, (1977)

Goldstein A.J., Kent D.R., David A., Prostaglandin E₂ vaginal suppositories in the treatment of intractable late-onset postpartum hemorrhage. A case report, Journal of Reproductive Medicine, 28, pp. 425-426, (1983)

Hayashi R.H., Castillo M.S., Noah M.L., Management of severe postpartum hemorrhage due to uterine atony using an analogue of prostaglandin F₂ alpha, Obstetrics and Gynecology, 58, pp. 426-429, (1981)

Hayashi R.H., Castillo M.S., Noah M.L., Management of severe postpartum hemorrhage with a prostaglandin F₂ alpha analogue, Obstetrics and Gynecology, 63, pp. 806-808, (1984)